FDA Postmarketing Safety Upgrades Gain Momentum In Congress
This article was originally published in The Tan Sheet
Executive Summary
A new FDA drug safety office would have jurisdiction over OTC drug marketing under a proposal from Sen. Chris Dodd (D-Conn.)